Page last updated: 2024-08-16

gatifloxacin and zithromax

gatifloxacin has been researched along with zithromax in 38 studies

Research

Studies (38)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (2.63)18.2507
2000's21 (55.26)29.6817
2010's15 (39.47)24.3611
2020's1 (2.63)2.80

Authors

AuthorsStudies
Appelbaum, PC; Credito, KL; DeWasse, B; Kosowska-Shick, K; McGhee, P; Pankuch, GA1
Appelbaum, PC; Bogdanovich, T; Clark, C; Dewasse, B; Ednie, L; McGhee, P; Smith, K1
Jansen, WT; Milatovic, D; Verel, A; Verhoef, J1
Lombardo, F; Obach, RS; Waters, NJ1
Appelbaum, PC; Ednie, LM; Kosowska-Shick, K; McGhee, P1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV1
Brunner, LS; Haas, W; Lee, JC; Morris, TW; Pillar, CM; Zurenko, GE1
Ekambaram, R; Raghunathan, M; Raghunathan, R; Rao, SS1
Hamasuna, R; Jensen, JS; Osada, Y1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Cai, L; Gilbert, GL; Kong, F; Oftadeh, S; Xiao, M; Xu, X; Zhou, F1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV1
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ1
Ekins, S; Williams, AJ; Xu, JJ1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Andrews, JM; Boswell, F; Brenwald, NP; Wise, R1
Bosso, JA; Enzweiler, KA; Friedrich, LV; Hoban, D; Wagner, D; White, RL1
Muhlestein, JB1
Choo, CM; Lim, T; Lim, YS; Ngan, CC; Toh, GL1
Daschner, F; Schmidt-Eisenlohr, E; Wenzler, S1
Pokrovskaia, EV1
Conti, CR1
Anderson, JL1
Mitchell, WM; Stratton, CW1
Boman, J; Taylor-Robinson, D1
Appelbaum, PC; Bozdogan, B; Choi, DR; Credito, K; Dewasse, B; Kosowska-Shick, K; Lin, G; McGhee, P; Pankuch, GA; Ryu, JM1
LaPlante, KL; Mersfelder, TL; Quilliam, BJ; Ward, KE1
Basnyat, B; Campbell, JI; Doan, CD; Dolecek, C; Dunstan, SJ; Duong, TL; Farrar, J; Ha, V; Le, TP; Luong, BH; Mai, NL; Nguyen, NR; Nguyen, TA; Nguyen, TB; Nguyen, TC; Nguyen, VM; Nguyen, VS; Nguyen, VV; Pham, ND; Phan, VB; Phung, QT; Schultsz, C; Stepniewska, K; To, SD; Tran, TC; Tran, TH; Tran, TP; Tran, TT; Vo, AH1
Chang, CL; Choi, GE; Kang, JE; Kim, JM; Kim, KH; Lee, EY; Tateda, K; Yamaguchi, K1
Kim, SJ; Toma, HS1
Butler, T1
Dave, SB; Kim, SJ; Toma, HS2
Allard, FD; Freitag, SK; Yee, EU1
Arjyal, A; Baker, S; Basnyat, B; Darton, T; Dolecek, C; Dongol, S; Farrar, JJ; Karkey, A; Thompson, CN; Thwaites, GE; Wolbers, M1
DeLisle, S; Gifford, J; Gill, C; Richards, K; Siddiqui, T; Vaeth, E; Wilson, L1
Balaji, V; Bandyopadhyay, R; Jasmine, S; Rupali, P; Sathyendra, S; Yadav, B1
Bykov, K; Fischer, MA; Gagne, JJ; Kattinakere-Sreedhara, S; Wang, J1

Reviews

3 review(s) available for gatifloxacin and zithromax

ArticleYear
Antibiotic treatment of atherosclerosis.
    Current opinion in lipidology, 2003, Volume: 14, Issue:6

    Topics: Animals; Anti-Bacterial Agents; Arteriosclerosis; Azithromycin; C-Reactive Protein; Cardiovascular Diseases; Chlamydophila Infections; Chlamydophila pneumoniae; Clarithromycin; Coronary Artery Disease; Coronary Restenosis; Diet, Atherogenic; Fluoroquinolones; Gatifloxacin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Models, Animal; Myocardial Ischemia; Rabbits; Randomized Controlled Trials as Topic; Roxithromycin; Treatment Outcome

2003
Treatment of typhoid fever in the 21st century: promises and shortcomings.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2011, Volume: 17, Issue:7

    Topics: Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Clinical Trials as Topic; Drug Resistance, Bacterial; Fluoroquinolones; Gatifloxacin; Humans; Salmonella typhi; Treatment Outcome; Typhoid Fever

2011
Dacryocystitis secondary to intranasal cocaine abuse: a case report and literature review.
    Orbit (Amsterdam, Netherlands), 2013, Volume: 32, Issue:6

    Topics: Administration, Intranasal; Adult; Anesthetics, Local; Anti-Bacterial Agents; Azithromycin; Cocaine; Cocaine-Related Disorders; Combined Modality Therapy; Dacryocystitis; Dacryocystorhinostomy; Fluoroquinolones; Gatifloxacin; Humans; Lacrimal Duct Obstruction; Male; Nasolacrimal Duct; Tomography, X-Ray Computed

2013

Trials

5 trial(s) available for gatifloxacin and zithromax

ArticleYear
A multi-center randomised controlled trial of gatifloxacin versus azithromycin for the treatment of uncomplicated typhoid fever in children and adults in Vietnam.
    PloS one, 2008, May-21, Volume: 3, Issue:5

    Topics: Adult; Anti-Bacterial Agents; Azithromycin; Child; Fluoroquinolones; Gatifloxacin; Humans; Microbial Sensitivity Tests; Salmonella; Species Specificity; Typhoid Fever

2008
Ophthalmic antibiotics and antimicrobial resistance a randomized, controlled study of patients undergoing intravitreal injections.
    Ophthalmology, 2011, Volume: 118, Issue:7

    Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Aza Compounds; Azithromycin; Conjunctiva; Drug Resistance, Bacterial; Fluoroquinolones; Gatifloxacin; Humans; Intravitreal Injections; Levofloxacin; Middle Aged; Moxifloxacin; Nasopharynx; Ofloxacin; Prospective Studies; Quinolines; Staphylococcal Infections

2011
Ophthalmic antibiotic use and multidrug-resistant staphylococcus epidermidis: a controlled, longitudinal study.
    Ophthalmology, 2011, Volume: 118, Issue:10

    Topics: Adult; Anti-Bacterial Agents; Aza Compounds; Azithromycin; Choroidal Neovascularization; Conjunctiva; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Follow-Up Studies; Gatifloxacin; Humans; Intravitreal Injections; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Prospective Studies; Quinolines; Staphylococcus epidermidis; Young Adult

2011
Changes in ocular flora in eyes exposed to ophthalmic antibiotics.
    Ophthalmology, 2013, Volume: 120, Issue:5

    Topics: Adult; Anti-Bacterial Agents; Aza Compounds; Azithromycin; Bacteria; Choroidal Neovascularization; Conjunctiva; Drug Resistance, Bacterial; Fluoroquinolones; Gatifloxacin; Humans; Intravitreal Injections; Longitudinal Studies; Moxifloxacin; Ofloxacin; Quinolines

2013
Treatment Response in Enteric Fever in an Era of Increasing Antimicrobial Resistance: An Individual Patient Data Analysis of 2092 Participants Enrolled into 4 Randomized, Controlled Trials in Nepal.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2017, Jun-01, Volume: 64, Issue:11

    Topics: Adolescent; Adult; Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Child; Drug Resistance, Multiple, Bacterial; Female; Fluoroquinolones; Gatifloxacin; Humans; Male; Microbial Sensitivity Tests; Nepal; Ofloxacin; Paratyphoid Fever; Salmonella paratyphi A; Salmonella typhi; Treatment Failure; Treatment Outcome; Typhoid Fever; Young Adult

2017

Other Studies

30 other study(ies) available for gatifloxacin and zithromax

ArticleYear
Multistep resistance selection and postantibiotic-effect studies of the antipneumococcal activity of LBM415 compared to other agents.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:2

    Topics: Amidohydrolases; Drug Resistance, Bacterial; Microbial Sensitivity Tests; Peptides; Pneumococcal Infections; Species Specificity; Streptococcus pneumoniae; Time Factors

2007
In vitro activity of DC-159a, a new broad-spectrum fluoroquinolone, compared with that of other agents against drug-susceptible and -resistant pneumococci.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:1

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Culture Media; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Mutation; Streptococcus pneumoniae

2008
In vitro activity of AR-709 against Streptococcus pneumoniae.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:3

    Topics: Anti-Bacterial Agents; Community-Acquired Infections; Drug Resistance, Multiple, Bacterial; Europe; Humans; Microbial Sensitivity Tests; Pyrimidines; Respiratory Tract Infections; Streptococcus pneumoniae

2008
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Comparative antipneumococcal activities of sulopenem and other drugs.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:6

    Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Lactams; Microbial Sensitivity Tests; Penicillin-Binding Proteins; Streptococcus pneumoniae

2009
Physicochemical determinants of human renal clearance.
    Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15

    Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight

2009
Besifloxacin, a novel fluoroquinolone, has broad-spectrum in vitro activity against aerobic and anaerobic bacteria.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:8

    Topics: Anti-Bacterial Agents; Azepines; Bacteria, Anaerobic; Drug Resistance, Bacterial; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests

2009
In vitro activity of a new quinoline derivative, ER-2, against clinical isolates of Mycoplasma pneumoniae and Mycoplasma hominis.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:12

    Topics: Anti-Bacterial Agents; Humans; Microbial Sensitivity Tests; Molecular Structure; Mycoplasma hominis; Mycoplasma pneumoniae; Pneumonia, Mycoplasma; Quinolines

2009
Antimicrobial susceptibilities of Mycoplasma genitalium strains examined by broth dilution and quantitative PCR.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:11

    Topics: Microbial Sensitivity Tests; Mycoplasma genitalium; Polymerase Chain Reaction

2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Distribution of serotypes, genotypes, and resistance determinants among macrolide-resistant Streptococcus pneumoniae isolates.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:3

    Topics: Anti-Bacterial Agents; Bacterial Proteins; Child, Preschool; DNA Transposable Elements; Drug Resistance, Bacterial; Erythromycin; Genotype; Humans; Macrolides; Microbial Sensitivity Tests; New South Wales; Pneumococcal Infections; Serotyping; Streptococcus pneumoniae

2010
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
    Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3

    Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations

2010
Developing structure-activity relationships for the prediction of hepatotoxicity.
    Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes

2010
A predictive ligand-based Bayesian model for human drug-induced liver injury.
    Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12

    Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands

2010
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
The activity of the methylpiperazinyl fluoroquinolone CG 5501: a comparison with other fluoroquinolones.
    The Journal of antimicrobial chemotherapy, 1997, Volume: 39, Issue:4

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Bacteroides fragilis; Chlamydia; Ciprofloxacin; Clarithromycin; Doxycycline; Enterobacter; Erythromycin; Fluoroquinolones; Gatifloxacin; Gram-Positive Bacteria; Haemophilus influenzae; Microbial Sensitivity Tests; Naphthyridines; Piperazines; Pseudomonas aeruginosa; Quinolones; Streptococcus pneumoniae

1997
Comparative activity of gatifloxacin and other antibiotics against 4009 clinical isolates of Streptococcus pneumoniae in the United States during 1999-2000.
    Diagnostic microbiology and infectious disease, 2002, Volume: 43, Issue:3

    Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Ceftriaxone; Child; Ciprofloxacin; Female; Fluoroquinolones; Gatifloxacin; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Penicillin Resistance; Penicillins; Pneumococcal Infections; Streptococcus pneumoniae; United States

2002
Susceptibility testing of Singapore strains of Mycoplasma hominis to tetracycline, gatifloxacin, moxifloxacin, ciprofloxacin, clindamycin, and azithromycin by the Etest method.
    Diagnostic microbiology and infectious disease, 2004, Volume: 48, Issue:3

    Topics: Anti-Bacterial Agents; Aza Compounds; Azithromycin; Ciprofloxacin; Clindamycin; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gatifloxacin; Humans; Microbial Sensitivity Tests; Moxifloxacin; Mycoplasma hominis; Quinolines; Sampling Studies; Sensitivity and Specificity; Singapore; Tetracycline

2004
Comparative in vitro activities of three new quinolones and azithromycin against aerobic pathogens causing respiratory tract and abdominal wound infections.
    Chemotherapy, 2004, Volume: 50, Issue:1

    Topics: Abdominal Injuries; Anti-Bacterial Agents; Aza Compounds; Azithromycin; Bacteria, Aerobic; Fluoroquinolones; Gatifloxacin; Humans; Levofloxacin; Methicillin Resistance; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Quinolines; Quinolones; Respiratory Tract Infections; Wound Infection

2004
[Final confirmation of inefficiency of antibiotics in secondary prevention of coronary heart disease. Results of PROVE IT (gatifloxacin trial) and ACES].
    Kardiologiia, 2004, Volume: 44, Issue:10

    Topics: Anti-Bacterial Agents; Azithromycin; C-Reactive Protein; Chlamydophila Infections; Chlamydophila pneumoniae; Coronary Disease; Double-Blind Method; Fluoroquinolones; Gatifloxacin; Humans; Placebos; Randomized Controlled Trials as Topic; Time Factors

2004
Antibiotics for coronary disease: it's time to move on.
    Clinical cardiology, 2004, Volume: 27, Issue:12

    Topics: Administration, Oral; Anti-Bacterial Agents; Azithromycin; Chlamydophila Infections; Chlamydophila pneumoniae; Coronary Disease; Fluoroquinolones; Gatifloxacin; Humans; Treatment Outcome

2004
Infection, antibiotics, and atherothrombosis--end of the road or new beginnings?
    The New England journal of medicine, 2005, Apr-21, Volume: 352, Issue:16

    Topics: Angina, Unstable; Anti-Bacterial Agents; Azithromycin; Cardiovascular Diseases; Chlamydophila Infections; Chlamydophila pneumoniae; Coronary Disease; Fluoroquinolones; Gatifloxacin; Humans; Myocardial Infarction; Treatment Failure

2005
Chlamydia pneumoniae and acute coronary syndrome.
    The New England journal of medicine, 2005, Aug-04, Volume: 353, Issue:5

    Topics: Animals; Anti-Bacterial Agents; Arteriosclerosis; Azithromycin; Chlamydophila Infections; Chlamydophila pneumoniae; Coronary Disease; Drug Resistance, Bacterial; Drug Therapy, Combination; Fluoroquinolones; Gatifloxacin; Humans

2005
The failure of antibiotics to prevent heart attacks.
    BMJ (Clinical research ed.), 2005, Aug-13, Volume: 331, Issue:7513

    Topics: Anti-Bacterial Agents; Azithromycin; Chlamydophila Infections; Chlamydophila pneumoniae; Coronary Artery Disease; Fluoroquinolones; Gatifloxacin; Humans; Myocardial Infarction; Treatment Failure

2005
Antipneumococcal activity of DW-224a, a new quinolone, compared to those of eight other agents.
    Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:6

    Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Azithromycin; Cefuroxime; Ciprofloxacin; Drug Resistance, Bacterial; Fluoroquinolones; Gatifloxacin; Gemifloxacin; Genes, Bacterial; Levofloxacin; Microbial Sensitivity Tests; Molecular Structure; Moxifloxacin; Naphthyridines; Ofloxacin; Quinolines; Streptococcus pneumoniae

2006
Prevalence of and risk factors for dysglycemia in patients receiving gatifloxacin and levofloxacin in an outpatient setting.
    Pharmacotherapy, 2008, Volume: 28, Issue:1

    Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Azithromycin; Creatinine; Diabetes Complications; Female; Fluoroquinolones; Gatifloxacin; Hospitals, Veterans; Humans; Hyperglycemia; Hypoglycemia; Levofloxacin; Male; Medical Records; Middle Aged; Multivariate Analysis; Ofloxacin; Prevalence; Retrospective Studies; Rhode Island; Risk Factors

2008
[Antimicrobial susceptibility patterns of Legionella isolates in the environment and in patients].
    The Korean journal of laboratory medicine, 2010, Volume: 30, Issue:1

    Topics: Anti-Bacterial Agents; Azithromycin; Ciprofloxacin; Clarithromycin; Clindamycin; Drug Resistance, Bacterial; Fluoroquinolones; Gatifloxacin; Gemifloxacin; Humans; Legionella; Legionellosis; Microbial Sensitivity Tests; Naphthyridines

2010
Decision support during electronic prescription to stem antibiotic overuse for acute respiratory infections: a long-term, quasi-experimental study.
    BMC infectious diseases, 2017, 07-31, Volume: 17, Issue:1

    Topics: Anti-Bacterial Agents; Azithromycin; Decision Support Systems, Clinical; Electronic Prescribing; Fluoroquinolones; Gatifloxacin; Humans; Maryland; Outpatients; Practice Patterns, Physicians'; Prescription Drug Overuse; Respiratory Tract Infections; Retrospective Studies

2017
Effectiveness of treatment regimens for Typhoid fever in the nalidixic acid-resistant S. typhi (NARST) era in South India.
    Tropical doctor, 2018, Volume: 48, Issue:3

    Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Ciprofloxacin; Cohort Studies; Drug Resistance, Multiple, Bacterial; Female; Fluoroquinolones; Gatifloxacin; Hospitalization; Humans; India; Male; Microbial Sensitivity Tests; Nalidixic Acid; Recurrence; Salmonella typhi; Treatment Outcome; Typhoid Fever; Young Adult

2018
Association between initiation of fluoroquinolones and hospital admission or emergency department visit for suicidality: population based cohort study.
    BMJ (Clinical research ed.), 2022, 10-04, Volume: 379

    Topics: Adult; Anti-Bacterial Agents; Azithromycin; Ciprofloxacin; Cohort Studies; Emergency Service, Hospital; Fluoroquinolones; Gatifloxacin; Gemifloxacin; Hospitals; Humans; Levofloxacin; Moxifloxacin; Norfloxacin; Retrospective Studies; Suicidal Ideation; Suicide; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections

2022